Bone health screening, education, and referral project in northwest Iowa: Creating a model for community pharmacies

Journal of the American Pharmacists Association

Volumn 48, Issue 3, 2008, Pages 379-387

  Johnson, June Felice ^a   Koenigsfeld, Carrie ^a   Hughell, Laurie ^b   Parsa, Rahul A ^a   Bravard, Susan ^c  

^a DRAKE UNIVERSITY   (United States)

^b Mercy Arthritis and Osteoporosis Center   (United States)

^c Mercy College of Health Sciences   (United States)

Author keywords

Bone mineral density screening; Community pharmacy; Disease prevention; Osteoporosis; Pharmaceutical care

Indexed keywords

ARTICLE; BONE DENSITY; CROSS-SECTIONAL STUDY; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MASS SCREENING; MEDICAL FEE; METHODOLOGY; MIDDLE AGED; NONBIOLOGICAL MODEL; ORGANIZATION AND MANAGEMENT; OSTEOPOROSIS; PATIENT EDUCATION; PHARMACIST; PHARMACY; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

BONE DENSITY; COMMUNITY PHARMACY SERVICES; CROSS-SECTIONAL STUDIES; FEE-FOR-SERVICE PLANS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IOWA; MASS SCREENING; MIDDLE AGED; MODELS, ORGANIZATIONAL; OSTEOPOROSIS; PATIENT EDUCATION AS TOPIC; PHARMACISTS; RISK ASSESSMENT; RISK FACTORS;

EID: 52049122422     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2008.07026     Document Type: Article

References (13)

1. National Osteoporosis Foundation. Fast facts. Accessed at www.nof.org/osteoporosis/diseasefacts.htm, December 2, 2006.
2. U.S. Department of Health and Human Services. Bone health and osteoporosis: a report of the Surgeon General. Accessed at www.surgeongeneral. gov/library/bonehealth/, December 2, 2006.
3. National Osteoporosis Foundation. Osteoporosis: physician's guide to prevention and treatment of osteoporosis. Washington, D.C.: National Osteoporosis Foundation; 1999.
4. Kirk JK, Spangler JG, Celestino FS. Prevalence of osteoporosis risk factors and treatment among women aged 50 years and older. Pharmacotherapy. 2000;20:405-9.
5. Andrade SE, Majumdar SR, Chan KA, et al. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture. Arch Intern Med. 2003;163:2052-7.
6. Elliott ME, Binkley NC, Carnes M, et al. Fracture risks for women in long-term care: high prevalence of calcaneal osteoporosis and hypovitaminosis D. Pharmacotherapy. 2003;23:702-10.
7. Cerulli J, Zeolla MM. Impact and feasibility of a community pharmacy bone mineral density screening and education program. J Am Pharm Assoc. 2004;44:161-7.
8. Goode JV, Swiger K, Bluml BM. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: Osteoporosis. J Am Pharm Assoc. 2004;44:152-60.
9. MacLaughlin EJ, MacLaughlin AA, Snella KA, et al. Osteoporosis screening and education in community pharmacies using a team approach. Pharmacotherapy. 2005;25:379-86.
10. Summers KM, Brock TP. Impact of pharmacist-led community bone mineral density screenings. Ann Pharmacother. 2005;39:243-8.
11. Elliot ME, Meek PD, Kanous NL, et al. Pharmacy-based bone mass measurements to assess osteoporosis risk. Ann Pharmacother. 2002;36:571-7.
12. Raisz LG. Screening for osteoporosis. N Engl J Med. 2005;353:164-71.
13. Grabe DW, Cerulli J, Stroup JS, et al. Comparison of the Achilles Express ultrasonometer with central dual-energy x-ray absorptiometry. Ann Pharmacother. 2006;40:830-5.